Analysis of Plasmid DNA from a Pharmaceutical Perspective

C. Russell Middaugh,Robert K. Evans,Donna L. Montgomery,Danilo R. Casimiro
DOI: https://doi.org/10.1021/js970367a
IF: 3.8
1998-02-01
Journal of Pharmaceutical Sciences
Abstract:The advent of gene therapy and polynucleotide-based vaccines has resulted in the use of plasmid DNA as a drug substance. Although biologically (cell or animal) based assays must currently be employed to establish the identity and potency of such drugs, we argue that in the future, a combination of microchip-based mutation detection devices combined with an array of chromatographic, electrophoretic, hydrodynamic, and spectroscopic methods can be employed to rigorously establish these properties. We review a variety of such methods in this context and also consider the issue of the chemical stability of plasmids. Extensive comparison is made to protein-based pharmaceuticals with the unique importance of polynucleotide sequence emphasized in comparison to protein tertiary structure.
pharmacology & pharmacy,chemistry, medicinal, multidisciplinary
What problem does this paper attempt to address?